Novartis to Invest $100 Million in Malaria Treatment Research
April 30th 2018The pharmaceutical giant will also launch a program committed to equitable pricing in malaria-endemic countries for new treatments along with expanding pediatric treatment availability and work to strengthen health care systems in 4 African nations.
Read More
New Clinical Trials To Test Monoclonal Antibodies for Prevention of Widespread Bacterial Infections
March 9th 2018The Antibacterial Resistance Leadership Group (ARLG) is working to enroll patients in clinical trials of 2 investigational monoclonal antibodies, with the ultimate goal of reducing antimicrobial resistance.
Read More
Researchers Identify Source of Inflammation and Tissue Damage in Chlamydia Infections
February 27th 2018The investigators concluded that 2 separate immune pathways are key players in the way in which the body deals with chlamydia: one pathway clears the bacteria, while another fuels inflammation and tissue damage.
Read More